Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on Equity

Design Therapeutics (DSGN) Return on Capital Employed (2021 - 2026)

Design Therapeutics' Return on Capital Employed history spans 1 years, with the latest figure at 9.18% for Q4 2021.

  • On a quarterly basis, Return on Capital Employed changed N/A to 9.18% in Q4 2021 year-over-year; TTM through Dec 2021 was 9.18%, a N/A change, with the full-year FY2021 number at 17.21%, changed N/A from a year prior.
  • Return on Capital Employed hit 9.18% in Q4 2021 for Design Therapeutics, down from 7.19% in the prior quarter.
  • Over the last five years, Return on Capital Employed for DSGN hit a ceiling of 4.84% in Q2 2021 and a floor of 9.18% in Q4 2021.